The European Medicines Agency (EMA) has published a frequently asked questions (FAQ) document for its Product Management Service (PMS) public API, dated 12 June 2026. The document provides technical guidance on authentication, data scope, endpoints, searching, pagination, rate limiting, and error handling for the API, which offers access to medicinal product data in FHIR format.
The PMS public API allows users to retrieve information on human and veterinary medicinal products authorized via the centralised procedure, including their status, substance details, and related resources. The API is publicly accessible without registration for read-only operations, but authenticated requests are required for certain endpoints. The FAQ clarifies that the API uses the HL7 FHIR standard (version R4) and supports JSON and XML response formats.
Key technical details include: the base URL for the API, search parameters (by product name, substance, marketing authorisation holder, and last updated date), pagination with sorting options, and rate limits to ensure fair usage. The document also explains propagation latency for data updates (typically within minutes) and caching mechanisms. The FAQ is intended to assist developers and stakeholders in integrating with the PMS public API, though it carries a disclaimer that it is not an official EMA commitment.
No prior coverage of this document exists in the last 180 days. The publication follows EMA's ongoing digital transformation efforts to improve transparency and access to regulatory data. The FAQ does not introduce new regulatory measures but serves as a practical resource for users of the PMS public API.